Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Pura Vida Investments

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 41
Average round size
info
The average size of a deal this fund participated in
$117M
Portfolio companies 28
Rounds per year 3.42
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.32
Exits 9
Key employees 2
Stages of investment
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Health Diagnostics
Summary

In 2012 was created Pura Vida Investments, which is appeared as VC. The main office of represented VC is situated in the New York. The company was established in North America in United States.

The high activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations.

Among the most popular fund investment industries, there are Pharmaceutical, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Acutus Medical, MedAvail, V-Wave. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Pura Vida Investments, startups are often financed by Pontifax, OrbiMed, GE Ventures. The meaningful sponsors for the fund in investment in the same round are Triventures, Redmile Group, Pontifax. In the next rounds fund is usually obtained by Deerfield Capital Management, Triventures, Royalties Fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pura Vida Investments:
Typical Co-investors
Pura Vida Investments is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pura Vida Investments:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ABC-CLIO Corporate -
Alpha Partners New York, New York, United States
Beijing Fucheng Gangjian Touzi Beijing, Beijing, China
e4e California, Santa Clara, United States
Fil Rouge Capital (FRC) Croatia, Grad Zagreb, Zagreb
GB Group Cheshire, Chester, United Kingdom
GO4IT Brazil, Rio de Janeiro, Rio De Janeiro
HLM Property Management England, London, United Kingdom
Huize Tianxia Chengdu Shi, China, Sichuan
IT Forest Corporation Japan, Tokyo
New England Clean Energy Council Boston, Massachusetts, United States
Premier Charlotte, North Carolina, United States
Rosemoor Capital Management LLC New York, New York, United States
Shenzhen Woer Heat-Shrinkable Material China, Guangdong Province, Pingshan District
SP Capital Central, Central Region, Singapore
Viventures California, San Mateo, United States
Yingkai Luyi Touzi China, Ningbo, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Alamar Biosciences

Biotechnology
Health Care
Medical
$100M26 Feb 2024 Hayward, California, United States

Monogram Health

Health Care
Hospital
Wellness
$375M09 Jan 2023 Nashville, Tennessee, United States

Beta Bionics

Biotechnology
Diabetes
Medical Device
$57M17 Feb 2022 Boston, Massachusetts, United States

Metagenomi

Artificial Intelligence
Machine Learning
$175M25 Jan 2022 California, United States

V-Wave

Biotechnology
Health Care
Medical
Medical Device
$98M16 Dec 2021 Israel, North District, Israel

NanoMosaic

Biopharma
Biotechnology
Genetics
Health Diagnostics
Therapeutics
$40M06 Dec 2021 Woburn, Massachusetts, United States

Exo

Health Care
Medical
Medical Device
$220M29 Jul 2021 Redwood City, California, United States

Willow

Health Care
Wearables
Wellness
Women's
$26M21 Apr 2021 Mountain View, California, United States

Vizgen

Biotechnology
$37M07 Apr 2021 Cambridge, Massachusetts, United States
News
Exo secures $200M toward commercializing ultrasound device

– Exo, a handheld ultrasound device and point-of-care workflow platform, raised $220m funding.
– The round was led by RA Capital Management and joined by BlackRock, Sands Capital, Avidity Partners, Pura Vida Investments and prior investors.
– The company plans to use the funding to commercialize its device and to build out its informatics platform.

Ultivue Announces $50M Financing Round

– Ultivue announced the completion of a $50m Series D round of financing.
– New investors include Ally Bridge Group, Pura Vida Investments and Tao Capital Partners.
– Previous venture investors in Ultivue who also participated in the financing include ARCH Ventures, Northpond Ventures and Applied Ventures, LLC.
– This additional funding will help Ultivue strengthen its position in the market, deliver innovative solutions to address the dynamic nature of tumor biology from precious tissue samples and to provide researchers and pathologists with the ability to fully realize the potential of tissue biomarkers within digital pathology workflows.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pura Vida Investments?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 41
Average round size 117M
Rounds per year 3.42
Peak activity year 2021
Lead investments 1
Follow on index 0.32
Exits 9
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Alamar Biosciences

Biotechnology
Health Care
Medical
$100M26 Feb 2024 Hayward, California, United States

Monogram Health

Health Care
Hospital
Wellness
$375M09 Jan 2023 Nashville, Tennessee, United States

Beta Bionics

Biotechnology
Diabetes
Medical Device
$57M17 Feb 2022 Boston, Massachusetts, United States

Metagenomi

Artificial Intelligence
Machine Learning
$175M25 Jan 2022 California, United States

V-Wave

Biotechnology
Health Care
Medical
Medical Device
$98M16 Dec 2021 Israel, North District, Israel

NanoMosaic

Biopharma
Biotechnology
Genetics
Health Diagnostics
Therapeutics
$40M06 Dec 2021 Woburn, Massachusetts, United States

Exo

Health Care
Medical
Medical Device
$220M29 Jul 2021 Redwood City, California, United States

Willow

Health Care
Wearables
Wellness
Women's
$26M21 Apr 2021 Mountain View, California, United States

Vizgen

Biotechnology
$37M07 Apr 2021 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: